Abstract:BACKGROUND:Acute-on-chronic liver failure (ACLF) is an acute decompensated syndrome based on chronic liver disease, while neutrophil recruitment is the most critical early step. C-X-C motif chemokine ligand 1 (CXCL1), a cytokine that recruits neutrophils, was significantly upregulated in both ACLF mice and patients with ACLF. This present study aims to explore the role of CXCL1 in the pathogenesis of ACLF.METHODS:We established an ACLF mouse model induced by carbon tetrachloride, lipopolysaccharide, and D-galactosamine, and used adeno-associated virus to achieve overexpression and knockdown of Cxcl1. We employed mass cytometry, flow cytometry, multiplex cytokine and chemokine analysis, Western blot, and reactive oxygen species (ROS) detection in mice blood and liver. ACLF patients (n = 10) and healthy controls (n = 5) were included, and their liver samples were stained using multiplex immunohistochemistry techniques.RESULTS:CXCL1 was significantly elevated in both ACLF mice and patients. CXCL1 recruits neutrophils by binding to the C-X-C motif chemokine receptor 2 on the surface of neutrophils, affects ACLF prognosis by generating ROS and mitochondrial depolarization and modulating caspase3-related apoptotic pathways. We found that the knockdown of CXCL1 attenuated the infiltration of neutrophils in the mouse liver, reduced the expression of inflammatory cytokines, and also significantly downregulated ROS production and caspase3-related hepatocyte apoptosis, thereby ameliorating the liver injury of ACLF.CONCLUSIONS:CXCL1 is a core player in the mobilization of neutrophils in ACLF, and the knockdown of Cxcl1 improves neutrophil infiltration, reduces ROS levels, and reduces hepatocyte apoptosis, thereby attenuating inflammation and liver injury in ACLF. Our results revealed a previously unknown link between CXCL1-induced neutrophil recruitment and ACLF, providing evidencing for potential therapies targeting ACLF.

CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin

Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury

A dual role for CRTH2 in acute lung injury

Neutrophils drive pulmonary vascular leakage in MHV-1 infection of susceptible A/J mice

SARS-CoV-2 Infection Triggers Profibrotic Macrophage Responses and Lung Fibrosis

Cis-acting Lnc-Cxcl2 Restrains Neutrophil-Mediated Lung Inflammation by Inhibiting Epithelial Cell CXCL2 Expression in Virus Infection

Neutrophil Extracellular Traps Mediate Severe Lung Injury Induced by Influenza a Virus H1N1 in Mice Coinfected with Staphylococcus Aureus

IFN-γ transforms the transcriptomic landscape and triggers myeloid cell hyperresponsiveness to cause lethal lung injury

Pathogenic neutrophilia drives acute respiratory distress syndrome in severe COVID-19 patients

Knockdown of CXCL1 Improves ACLF by Reducing Neutrophil Recruitment to Attenuate ROS Production and Hepatocyte Apoptosis.

CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats

CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS

Mechanism Of Cxc Chemokine Ligand 5 (Cxcl5)/Cxc Chemokine Receptor 2 (Cxcr2) Bio-Axis In Mice With Acute Respiratory Distress Syndrome

Locally organised and activated Fth1hi neutrophils aggravate inflammation of acute lung injury in an IL-10-dependent manner

A narrative review of chemokine receptors CXCR1 and CXCR2 and their role in acute respiratory distress syndrome

Mirna-200C-3p is Crucial in Acute Respiratory Distress Syndrome

A Critical Role for P2X7 Receptor-Induced VCAM-1 Shedding and Neutrophil Infiltration During Acute Lung Injury.

The Role Of C5a In Acute Lung Injury Induced By Highly Pathogenic Viral Infections

The Link Between Neutrophils, NETs, and NLRP3 Inflammasomes: the Dual Effect of CD177 and Its Therapeutic Potential in Acute Respiratory Distress Syndrome/acute Lung Injury.

IL-1 Mediates Tissue-Specific Inflammation and Severe Respiratory Failure in COVID-19

Role of CCR2 and IL-8 in acute lung injury: a new mechanism and therapeutic target.